Latest filing published 18 Mar 2014 for Aegerion Pharmaceuticals, Inc., €19k.
Insider track record
No signal scores available.
Mark Sumeray: trading record in brief
Mark Sumeray discloses dealings in Aegerion Pharmaceuticals, Inc. to SEC (Form 4). The record holds 59 filings, for trades running from 22 April 2013 to 14 March 2014.
Sales make up the whole of the open-market record (43 sales, €2.3M). Other entries cover 16 option exercises. Since January 2014: no purchases and 9 sales on the market.
On 18 March 2014 came the latest disclosure, an option exercise for €19k in Aegerion Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Mark Sumeray
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000 shares@ US$13.01Common StockSEC:0001209191-14-021383:0
- 300 shares@ US$49.69Common StockSEC:0001209191-14-021383:1
- 900 shares@ US$51.31Common StockSEC:0001209191-14-021383:2
- 800 shares@ US$51.98Common StockSEC:0001209191-14-021383:3
- 2,000 shares@ US$13.01Common StockSEC:0001209191-14-011270:0
- 1,500 shares@ US$63.14Common StockSEC:0001209191-14-011270:1
- 500 shares@ US$64.52Common StockSEC:0001209191-14-011270:2
- 2,000 shares@ US$13.01Common StockSEC:0001209191-14-004013:0
- 1,900 shares@ US$58.59Common StockSEC:0001209191-14-004013:1
- 100 shares@ US$59.51Common StockSEC:0001209191-14-004013:2
- 1,000 shares@ US$13.01Common StockSEC:0001209191-14-001746:0
- 400 shares@ US$70.22Common StockSEC:0001209191-14-001746:1
- 600 shares@ US$71.41Common StockSEC:0001209191-14-001746:2
- 2,000 shares@ US$13.01Common StockSEC:0001209191-13-057350:0
- 1,800 shares@ US$66.23Common StockSEC:0001209191-13-057350:1
- 200 shares@ US$67.38Common StockSEC:0001209191-13-057350:2
- 3,000 shares@ US$13.01Common StockSEC:0001209191-13-055282:0
- 2,400 shares@ US$70.23Common StockSEC:0001209191-13-055282:1
- 600 shares@ US$71.20Common StockSEC:0001209191-13-055282:2
- 2,000 shares@ US$13.01Common StockSEC:0001181431-13-059663:0
- 489 shares@ US$74.93Common StockSEC:0001181431-13-059663:1
- 1,011 shares@ US$75.89Common StockSEC:0001181431-13-059663:2
- 500 shares@ US$77.63Common StockSEC:0001181431-13-059663:3
- 3,500 shares@ US$13.01Common StockSEC:0001181431-13-056829:0
- 1,400 shares@ US$82.76Common StockSEC:0001181431-13-056829:1
25 of 59 declarations
